Importance of granulocyte colony-stimulating factor prophylaxis in therapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone given every 14 days for diffuse large B-cell lymphoma in routine clinical practice

Autor: Ulrich Jaeger, Corrine Haioun, Matthias Schwenkglenks, Ruth Pettengell, Hans Erik Johnsen, Francesca Gaia Rossi, Pieternella J. Lugtenburg, Gregor Verhoef, Antonio Salar, Kate Bendall, Ulrich Duehrsen

Publikováno v: Johnsen, H E, Haioun, C, Lugtenburg, P J, Salar, A, Jaeger, U, Pettengell, R, Rossi, F G, Verhoef, G, Schwenkglenks, M, Bendall, K & Duehrsen, U 2012, ' Importance of granulocyte colony-stimulating factor prophylaxis in therapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone given every 14 days for diffuse large B-cell lymphoma in routine clinical practice ', Leukemia and Lymphoma, vol. 53, no. 5, pp. 982-4 . https://doi.org/10.3109/10428194.2011.643407

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::464e05afefac80fa56131980cf45a679
https://doi.org/10.3109/10428194.2011.643407

External validation of a risk model of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma

Autor: Matthias Schwenkglenks, Ruth Pettengell, Zsolt Szabo, Alena M. Pfeil, Kate Bendall

Publikováno v: Leukemialymphoma. 54(11)

Febrile neutropenia (FN) is a common and serious complication of chemotherapy treatment. Clinical risk models may help to identify patients at high risk of FN but must undergo external validation before implementation in medical practice. Therefore,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53f5953e6cbe3af346262b7bf350ad01
https://pubmed.ncbi.nlm.nih.gov/23452152

Economic costs of chemotherapy-induced febrile neutropenia among patients with non-Hodgkin's lymphoma in European and Australian clinical practice

Autor: A. Marciniak, Ruth Pettengell, Aurelie Danel, Derek Weycker, Kate Bendall, Michael Lipsitz

Publikováno v: BMC Cancer
BMC Cancer, Vol 12, Iss 1, p 362 (2012)

Background Economic implications of chemotherapy-induced febrile neutropenia (FN) in European and Australian clinical practice are largely unknown. Methods Data were obtained from a European (97%) and Australian (3%) observational study of patients w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b4e81c3c9fe7b01e74e2d3311489337
https://openaccess.sgul.ac.uk/id/eprint/103227/1/1471-2407-12-362.pdf

Impact of febrile neutropenia on R-CHOP chemotherapy delivery and hospitalizations among patients with diffuse large B-cell lymphoma

Autor: Ruth, Pettengell, Hans E, Johnsen, Hans E, Johnson, Pieternella J, Lugtenburg, Antonio Salar, Silvestre, Ulrich, Dührsen, Francesca G, Rossi, Matthias, Schwenkglenks, Kate, Bendall, Zsolt, Szabo, Ulrich, Jaeger

Publikováno v: Pettengell, R, Johnsen, H E, Lugtenburg, P J, Silvestre, A S, Dührsen, U, Rossi, F G, Schwenkglenks, M, Bendall, K, Szabo, Z & Jaeger, U 2012, ' Impact of febrile neutropenia on R-CHOP chemotherapy delivery and hospitalizations among patients with diffuse large B-cell lymphoma ', Supportive Care in Cancer, vol. 20, no. 3, pp. 647-52 . https://doi.org/10.1007/s00520-011-1306-6
Supportive Care in Cancer

Purpose\ud \ud This analysis from an observational study of clinical practice describes the impact of febrile neutropenia (FN) on chemotherapy delivery and hospitalizations.\ud Methods\ud \ud Adults with diffuse large B-cell lymphoma (DLBCL) schedule

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::988c7ca4081ba674c0c63ef051bd2989
https://pure.au.dk/portal/da/publications/impact-of-febrile-neutropenia-on-rchop-chemotherapy-delivery-and-hospitalizations-among-patients-with-diffuse-large-bcell-lymphoma(c36e5c35-65bd-49c6-86a0-8b042df48fd9).html

Cost of Chemotherapy-Induced Febrile Neutropenia Treated in Inpatient, Outpatient, and Home Settings Among Adults with Non-Hodgkin's Lymphoma in European Clinical Practice

Autor: Kate Bendall, Ruth Pettengell, Michael Lipsitz, Derek Weycker, Aurelie Danel

Publikováno v: Blood. 118:4200-4200

Abstract 4200 Background: Neutropenia is a frequent complication of myelosuppressive chemotherapy. In the presence of fever or other evidence of infection, neutropenia typically necessitates inpatient care, although a minority of less severe episodes

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::23a4d0caccd76d0c8bf5f08d72fd422b
https://doi.org/10.1182/blood.v118.21.4200.4200